Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive data collection aims to improve stroke care

NCT ID NCT07482124

Knowledge-focused Sponsor: UMC Utrecht Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a registry that collects detailed information from 1000 adults who have had a spontaneous subarachnoid hemorrhage, a type of stroke. Researchers will analyze treatments and outcomes to find what works best. No new treatments are being tested; the goal is to learn from real-world care to improve future patient management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could help doctors identify the best treatments for subarachnoid hemorrhage, leading to better patient outcomes.
What could go wrong
This is an observational registry, not a treatment trial. It collects data but does not test a new therapy, so direct patient benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with spontaneous subarachnoid hemorrhage

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Spontaneous subarachnoid hemorrhage with blood in the basal cisterns and/or major fissures on non-contrast head computed tomography (CT), or xanthochromia of cerebrospinal fluid confirmed by spectrophotometric analysis. * Eligible etiologies/patterns: * Aneurysmal SAH * SAH from other intracranial vascular malformation (e.g. AVM, dural AVF) * Perimesencephalic SAH * Non-perimesencephalic angiogram negative SAH * SAH from intracranial artery dissection Exclusion Criteria: * Traumatic, neoplastic, infection related (except mycotic aneurysms), or iatrogenic SAH * Isolated convexity SAH

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Subarachnoid hemorrhage, spontaneous are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Subarachnoid hemorrhage, spontaneous

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Amsterdam University Medical Center

    RECRUITING

    Amsterdam, North Holland, 1105AZ, Netherlands

  • Elisabeth-Tweesteden Hospital

    RECRUITING

    Tilburg, North Brabant, 5022GC, Netherlands

  • Erasmus University Medical Center

    RECRUITING

    Rotterdam, South Holland, 3015 GD, Netherlands

  • Haaglanden Medical Center

    RECRUITING

    The Hague, South Holland, 2512 VA, Netherlands

  • Isala

    RECRUITING

    Zwolle, Overijssel, 8025 AB, Netherlands

  • Maastricht University Medical Center+

    RECRUITING

    Maastricht, Limburg, 6229 HX, Netherlands

  • Radboud University Medical Center

    RECRUITING

    Nijmegen, Gelderland, 6525 GA, Netherlands

  • University Medical Center Groningen

    RECRUITING

    Groningen, Provincie Groningen, 9713 GZ, Netherlands

  • Utrecht University Medical Center

    RECRUITING

    Utrecht, Utrecht, 3584 CX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.